Copyright Reports & Markets. All rights reserved.

Global Hospital Acquired Infections Control Market Size, Status and Forecast 2019-2025

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Hospital Acquired Infections Control Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Hospital Acquired Infections Control Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Diagnostic techniques
    • 1.4.3 Dleaning and sterilization
    • 1.4.4 Treatment
  • 1.5 Market by Application
    • 1.5.1 Global Hospital Acquired Infections Control Market Share by Application: 2020 VS 2026
    • 1.5.2 General Hospital
    • 1.5.3 Infectious Disease Hospital
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Hospital Acquired Infections Control Market Perspective (2015-2026)
  • 2.2 Global Hospital Acquired Infections Control Growth Trends by Regions
    • 2.2.1 Hospital Acquired Infections Control Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Hospital Acquired Infections Control Historic Market Share by Regions (2015-2020)
    • 2.2.3 Hospital Acquired Infections Control Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Hospital Acquired Infections Control Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Hospital Acquired Infections Control Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Hospital Acquired Infections Control Players by Market Size
    • 3.1.1 Global Top Hospital Acquired Infections Control Players by Revenue (2015-2020)
    • 3.1.2 Global Hospital Acquired Infections Control Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Hospital Acquired Infections Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Hospital Acquired Infections Control Market Concentration Ratio
    • 3.2.1 Global Hospital Acquired Infections Control Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections Control Revenue in 2019
  • 3.3 Hospital Acquired Infections Control Key Players Head office and Area Served
  • 3.4 Key Players Hospital Acquired Infections Control Product Solution and Service
  • 3.5 Date of Enter into Hospital Acquired Infections Control Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Hospital Acquired Infections Control Historic Market Size by Type (2015-2020)
  • 4.2 Global Hospital Acquired Infections Control Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Hospital Acquired Infections Control Market Size by Application (2015-2020)
  • 5.2 Global Hospital Acquired Infections Control Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Hospital Acquired Infections Control Market Size (2015-2020)
  • 6.2 Hospital Acquired Infections Control Key Players in North America (2019-2020)
  • 6.3 North America Hospital Acquired Infections Control Market Size by Type (2015-2020)
  • 6.4 North America Hospital Acquired Infections Control Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Hospital Acquired Infections Control Market Size (2015-2020)
  • 7.2 Hospital Acquired Infections Control Key Players in Europe (2019-2020)
  • 7.3 Europe Hospital Acquired Infections Control Market Size by Type (2015-2020)
  • 7.4 Europe Hospital Acquired Infections Control Market Size by Application (2015-2020)

8 China

  • 8.1 China Hospital Acquired Infections Control Market Size (2015-2020)
  • 8.2 Hospital Acquired Infections Control Key Players in China (2019-2020)
  • 8.3 China Hospital Acquired Infections Control Market Size by Type (2015-2020)
  • 8.4 China Hospital Acquired Infections Control Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Hospital Acquired Infections Control Market Size (2015-2020)
  • 9.2 Hospital Acquired Infections Control Key Players in Japan (2019-2020)
  • 9.3 Japan Hospital Acquired Infections Control Market Size by Type (2015-2020)
  • 9.4 Japan Hospital Acquired Infections Control Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Hospital Acquired Infections Control Market Size (2015-2020)
  • 10.2 Hospital Acquired Infections Control Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Hospital Acquired Infections Control Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Hospital Acquired Infections Control Market Size by Application (2015-2020)

11 India

  • 11.1 India Hospital Acquired Infections Control Market Size (2015-2020)
  • 11.2 Hospital Acquired Infections Control Key Players in India (2019-2020)
  • 11.3 India Hospital Acquired Infections Control Market Size by Type (2015-2020)
  • 11.4 India Hospital Acquired Infections Control Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Hospital Acquired Infections Control Market Size (2015-2020)
  • 12.2 Hospital Acquired Infections Control Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Hospital Acquired Infections Control Market Size by Type (2015-2020)
  • 12.4 Central & South America Hospital Acquired Infections Control Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Advanced Sterilization Products
    • 13.1.1 Advanced Sterilization Products Company Details
    • 13.1.2 Advanced Sterilization Products Business Overview
    • 13.1.3 Advanced Sterilization Products Hospital Acquired Infections Control Introduction
    • 13.1.4 Advanced Sterilization Products Revenue in Hospital Acquired Infections Control Business (2015-2020))
    • 13.1.5 Advanced Sterilization Products Recent Development
  • 13.2 Becton Dickinson
    • 13.2.1 Becton Dickinson Company Details
    • 13.2.2 Becton Dickinson Business Overview
    • 13.2.3 Becton Dickinson Hospital Acquired Infections Control Introduction
    • 13.2.4 Becton Dickinson Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.2.5 Becton Dickinson Recent Development
  • 13.3 Belimed AG
    • 13.3.1 Belimed AG Company Details
    • 13.3.2 Belimed AG Business Overview
    • 13.3.3 Belimed AG Hospital Acquired Infections Control Introduction
    • 13.3.4 Belimed AG Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.3.5 Belimed AG Recent Development
  • 13.4 bioMerieux
    • 13.4.1 bioMerieux Company Details
    • 13.4.2 bioMerieux Business Overview
    • 13.4.3 bioMerieux Hospital Acquired Infections Control Introduction
    • 13.4.4 bioMerieux Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.4.5 bioMerieux Recent Development
  • 13.5 Cantel
    • 13.5.1 Cantel Company Details
    • 13.5.2 Cantel Business Overview
    • 13.5.3 Cantel Hospital Acquired Infections Control Introduction
    • 13.5.4 Cantel Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.5.5 Cantel Recent Development
  • 13.6 Cepheid
    • 13.6.1 Cepheid Company Details
    • 13.6.2 Cepheid Business Overview
    • 13.6.3 Cepheid Hospital Acquired Infections Control Introduction
    • 13.6.4 Cepheid Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.6.5 Cepheid Recent Development
  • 13.7 Getinge
    • 13.7.1 Getinge Company Details
    • 13.7.2 Getinge Business Overview
    • 13.7.3 Getinge Hospital Acquired Infections Control Introduction
    • 13.7.4 Getinge Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.7.5 Getinge Recent Development
  • 13.8 Merck & Co.
    • 13.8.1 Merck & Co. Company Details
    • 13.8.2 Merck & Co. Business Overview
    • 13.8.3 Merck & Co. Hospital Acquired Infections Control Introduction
    • 13.8.4 Merck & Co. Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.8.5 Merck & Co. Recent Development
  • 13.9 Nordion
    • 13.9.1 Nordion Company Details
    • 13.9.2 Nordion Business Overview
    • 13.9.3 Nordion Hospital Acquired Infections Control Introduction
    • 13.9.4 Nordion Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.9.5 Nordion Recent Development
  • 13.10 Pfizer
    • 13.10.1 Pfizer Company Details
    • 13.10.2 Pfizer Business Overview
    • 13.10.3 Pfizer Hospital Acquired Infections Control Introduction
    • 13.10.4 Pfizer Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 13.10.5 Pfizer Recent Development
  • 13.11 Roche
    • 10.11.1 Roche Company Details
    • 10.11.2 Roche Business Overview
    • 10.11.3 Roche Hospital Acquired Infections Control Introduction
    • 10.11.4 Roche Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 10.11.5 Roche Recent Development
  • 13.12 Sakura Seiki
    • 10.12.1 Sakura Seiki Company Details
    • 10.12.2 Sakura Seiki Business Overview
    • 10.12.3 Sakura Seiki Hospital Acquired Infections Control Introduction
    • 10.12.4 Sakura Seiki Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 10.12.5 Sakura Seiki Recent Development
  • 13.13 Steris
    • 10.13.1 Steris Company Details
    • 10.13.2 Steris Business Overview
    • 10.13.3 Steris Hospital Acquired Infections Control Introduction
    • 10.13.4 Steris Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 10.13.5 Steris Recent Development
  • 13.14 TSO3
    • 10.14.1 TSO3 Company Details
    • 10.14.2 TSO3 Business Overview
    • 10.14.3 TSO3 Hospital Acquired Infections Control Introduction
    • 10.14.4 TSO3 Revenue in Hospital Acquired Infections Control Business (2015-2020)
    • 10.14.5 TSO3 Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Hospital Acquired Infections Control market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections Control market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Advanced Sterilization Products
    Becton Dickinson
    Belimed AG
    bioMerieux
    Cantel
    Cepheid
    Getinge
    Merck & Co.
    Nordion
    Pfizer
    Roche
    Sakura Seiki
    Steris
    TSO3

    Market segment by Type, the product can be split into
    Diagnostic techniques
    Dleaning and sterilization
    Treatment
    Market segment by Application, split into
    General Hospital
    Infectious Disease Hospital

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now